Osteoprotegerin mitigates tail suspension-induced osteopenia

Bone

Volumn 26, Issue 5, 2000, Pages 443-449

  Bateman, T A ^a   Dunstan, C R ^b   Ferguson, V L ^a   Lacey, D L ^b   Ayers, R A ^a   Simske, S J ^a  

^a UCB 450   (United States)

^b AMGEN INC   (United States)

Author keywords

Disuse; Histomorphometry; Mechanical testing; Microhardness; Osteoprotegerin; Tail suspension

Indexed keywords

OSTEOPROTEGERIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MASS; CONTROLLED STUDY; FEMUR; HUMERUS; MOUSE; NONHUMAN; OSTEOPENIA; TIBIA;

ANIMALS; BONE DISEASES, METABOLIC; GLYCOPROTEINS; HINDLIMB SUSPENSION; MALE; MICE; MICE, INBRED C57BL; OSTEOPROTEGERIN; PLACEBOS; RATS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 0034083360     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(00)00256-8     Document Type: Article

References (34)

1. Akatsu T., Murakami T., Nishikawa M., Ono K., Shinomiya N., Tsuda E., Mochizuki S., Yamaguchi K., Kinosaki M., Higahio K., Yamamoto M., Motoyoshi K., Nagata N. Osteoclastogenesis inhibitory factor suppresses osteoclast survival by interfering in the interaction of stromal cells with osteoclasts. Biochem Biophys Res Commun. 250:1998;229-234.
2. Broz J.J., Simske S.J., Greenberg A.R., Luttges M.W. Effects of rehydration on the flexural properties of whole mouse long bones. J Biomech Eng. 115:1993;447-449.
3. Bucay N., Sorosi I., Dunstan C.R., Morony S., Tarrley J., Capparelli C., Scully S., Tan H.L., Xu W., Lacey D.L., Boyle W.J., Simonet W.S. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Devel. 12:1998;1260-1268.
4. Currey J.D. The effects of drying and re-wetting on some mechanical properties of cortical bone. J Biomech. 21:1988;439-441.
5. Currey J.D., Brear K. Hardness, Young's modulus and yield stress in mammalian mineralized tissues. J Mater Sci Mater Med. 1:1990;14-20.
6. Dempster V.B., Dunstan C.R., Kelley M., Stein L., Horbert W., Cosman F., Lindsay R. Effects of osteoprotegerin on human and rat osteoclasts. Bone. 23:(Suppl.):1998;S432.
7. Evans G.P., Behiri J.C., Currey J.D., Bonfield W. Microhardness and Young's modulus in cortical bone exhibiting a wide range of mineral volume fractions, and in a bone analogue. J Mater Sci Mater Med. 1:1990;38-43.
8. Ferguson V.L., Bateman T.A., Ayers R.A., Zimmerman R.J., Simske S.J. Effects of tail suspension and insulin-like growth factor-1 on mouse bone mechanical properties. Grav Space Biol Bul. 11:1997;17.
9. Fielder P.J., Morey E.R., Roberts W.E. Osteoblast histogenesis in periodontal ligament and tibial metaphysis during simulated weightlessness. Aviat Space Environ Med. 57:1986;1125-1130.
10. Globus R.K., Bikle D.D., Morey-Holton E. The temporal response of bone to unloading. Endocrinology. 118:1986;733-742.
11. Halloran B.P., Bikle D.D., Cone C.M., Morey-Holton E. Glucocorticoids and inhibition of bone formation induced by skeletal unloading. Am J Phys. 244:1988;E875-E879.
12. Hofbauer L.C., Dunstan C.R., Spelsberg T.C., Riggs B.L., Khosla S. Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenic protein-2, and cytokines. Biochem Biophys Res Commun. 250:1998;776-781.
13. Hofbauer L.C., Khosla S., Dunstan C.R., Spelsberg T.C., Riggs B.L. Estrogen stimulates production of anti-resorptive cytokine receptor osteoprotegerin in human osteoblastic cells. Bone. 23:(Suppl.):1998;S172.
14. Jee W.S., Wronski T.J., Morey E.R., Kimmel D.B. Effects of spaceflight on trabecular bone in rats. Am J Phys. 244:1983;R310-R316.
15. Lacey D.L., Timms E., Tan H.-L., Kelley M.J., Dunstan C.R., Burgess T., Elliot R., Colombero A., Elliot G., Scully S., Hsu H., Sullivan J., Hawkins N., Davy E., Capparelli C., Eli A., Qian Y.-X., Kaufman S., Sarosi I., Shalhoub V., Senaldi G., Gou J., Delaney J., Boyle W.J. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 93:1998;165-176.
16. Machwate M., Zerath E., Holy X., Hott M., Modrowski D., Malouvier A., Marie P.J. Skeletal unloading in rats decreases proliferation of rat bone and marrow-derived osteoblastic cells. Am J Phys. 264:1993;E790-E799.
17. Mizuno A., Amizuka N., Irie K., Murakami A., Fujise N., Kanno T., Sato Y., Nakagawa N., Yasuda H., Mochizuki S., Gomibuchi T., Yano K., Shima N., Washida N., Tsuda E., Morinaga T., Higashio K., Ozawa H. Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin. Biochem Biophys Res Commun. 247:1998;610-615.
18. Ohlsson C., Sjogren K., Brandstrom H., Jonsson K., Ljunggren O., Vidal O.A. Osteoprotegerin mRNA expression in human osteoblast-like cells Reciprocal regulation by glucocorticoids and IL-1α Bone. 23:(Suppl.):1998;S529.
19. Parfitt A.M., Drezner M.K., Glorieux F.H., Kanis J.A., Malluche H., Meunier P.J., Ott S.M., Recker R.R. Bone histomorphometry Standardization of nomenclature, symbols, and units . J Bone Miner Res. 2:1987;595-610.
20. Shalhoub V., Faust J., Boyle W.J., Dunstan C.R., Kelley M., Kaufman S., Scully S., Yin S., Van G., Lacey D.L. Characterization of OPGL-induced osteoclast formation from peripheral bood mononuclear cell precursors. Bone. 23:(Suppl.):1998;S217.
21. Simonet W.S., Lacey D.L., Dunstan C.R., Kelley M., Chang M.S., Luthy R., Nguyen H.Q., Wooden S., Bennett L., Boone T., Shimamota G., DeRose M., Elliot R., Colombero A., Tan H.L., Trail G., Sullivan J., Davy E., Bucay N., Renshaw-Gregg L., Hughes T.M., Hill D., Pattison W., Campbell P., Sander S., Van G., Tarpley J., Derby P., Lee R., Boyle W.J. Amgen EST program. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell. 89:1997;309-319.
22. Simske S.J., Broz J.J., Fleet M.L., Schmeister T.A., Gayles E.C., Luttges M.W. Contribution of dietary and loading changes to the effects of suspension on mouse femora. J Exp Zool. 269:1994;277-285.
23. Simske S.J., Broz J.J., Luttges M.W. Effect of suspension on mouse bone microhardness. J Mater Sci Mater Med. 6:1995;486-491.
24. Simske S.J., Greenberg A.R., Luttges M.W. Tail suspension induced osteopenia in mouse femora An animal model for microgravity exposure . J Mater Sci Mater Med. 2:1991;43-50.
25. Simske S.J., Guerra K.M., Greenberg A.R., Luttges M.W. The physical and mechanical effects of suspension-induced osteopenia in mouse femora. J Biomech. 25:1992;489-499.
26. Simske S.J., Luttges M.W., Allen K.A. Effect of oral calcium and calcium + fluoride treatments on mouse bone properties during suspension. Biomimetics. 1:1993;311-327.
27. Simske S.J., Luttges M.W., Allen K.A., Gayles E.C. The role of sex and genotype on antiorthostatic suspension effects on the mouse peripheral skeleton. Aviat Space Environ Med. 65:1994;123.
28. Simske, S. J., Wachtel, H., and Luttges, M. W. Effect of localized pulsed electromagnetic fields on tail-suspension osteopenia in growing mice. J Mater Sci Mater Med 12:101-116.
29. Vico L., Chappard D., Palle S., Bakulin A.V., Novikov V.E., Alexandre C. Trabecular bone remodeling after seven days of weightlessness exposure (Biocosmos 1667). Am J Phys. 255:1988;R243-R247.
30. Wronski T.J., Morey E.R. Skeletal abnormalities in rats induced by simulated weightlessness. Metab Bone Dis Rel Res. 4:1982;69-75.
31. Wronski T.J., Morey E.R. Effects of spaceflight on periosteal bone formation in rats. Am J Phys. 244:1983;R305-R309.
32. Yasuda H., Shima N., Nakagawa N., Mochizuki S., Yano K., Fujise N., Sato Y., Goto M., Yamaguchi K., Kuriyama M., Kanno T., Murakami A., Tsuda E., Morinaga T., Higashio K. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG) A mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro . Endocrinology. 139:1998;1329-1337.
33. Yasuda H., Shima N., Nakagawa N., Yamaguchi K., Kinosaki M., Mochizuki S., Tomoyaus A., Yano K., Goto M., Murakami A., Tsuda E., Morinaga T., Higashio K., Udagawa N., Takahashi N., Suda T. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci. 95:1998;3597-3602.
34. Zhang R., Supowit S.G., Klein G.L., Lu Z., Christensen M.D., Lozano R., Simmons D.J. Rat tail suspension reduces messenger RNA level for growth factors and osteopontin and decreases the osteoblastic differentiation of bone marrow stromal cells. J Bone Miner Res. 10:1995;415-423.